The treatment of resistant hypertension has received a boost with the recent US Food and Drug Administration (FDA) approval of a completely new therapeutic approach that reduces activity in the ...

A systolic blood pressure (SBP) reduction of 4.5 mm Hg is not good enough—for an invasive procedure. At the virtual American College of Cardiology (ACC) 2021 Scientific Session, Ajay Kirtane, MD, from ...

Evidence from trials designed and launched after release of the disappointing results of SYMPLICITY HTN-3 supports renal denervation as a third major option for the treatment of hypertension alongside ...

Renal denervation using radiofrequency energy is a cost-effective and high-value intervention for the treatment of uncontrolled hypertension from the perspective of the US healthcare system, an ...

(RTTNews) - Medtronic plc (MDT) said that SYMPLICITY HTN-3 trial data showed sustained long-term blood pressure reductions with its renal denervation procedure. According to the company, patients who ...

Egypt’s Healthcare Authority (EHA) said on Sunday its Fayrouz Medical Complex in South Sinai has successfully performed the ...

Please provide your email address to receive an email when new articles are posted on . Renal denervation therapy is associated with a sustained reduction in BP out to 3 years as well as an ...

Despite strict adherence to treatment, the patient's hypertension remained dangerously uncontrolled, leading to repeated hospital admissions. Renal denervation is an advanced minimally invasive ...

Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of a radiofrequency renal ...